Clinical Trials

BioCity Biopharma's Cancer Therapy BC2027 Gets FDA Nod for Phase 1 Trials

BioCity Biopharma announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Pha...

 April 10, 2024 | News

Dizal's Sunvozertinib Secures FDA Breakthrough Therapy Designation for First-Line EGFR Mutated NSCLC Treatment

Dizal announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation (BTD) to its sunvozertinib as the firs...

 April 08, 2024 | News

Ractigen Therapeutics Launches Pioneering Phase I Clinical Trial for Bladder Cancer with First Patient Dosed in Collaboration with GenesisCare

Ractigen Therapeutics, a pioneer in small activating RNA (saRNA) therapeutics, achieved a major milestone with the first patient dosed in its First-in-huma...

 April 04, 2024 | News

YolTech Therapeutics Initiates Clinical Trial for Gene Editing Treatment YOLT-101 Targeting Familial Hypercholesterolemia

YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being develope...

 April 03, 2024 | News

Innovent and HUTCHMED's Endometrial Cancer Therapy Receives Priority Review by China's NMPA

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

 April 03, 2024 | News

Alebund Pharmaceuticals Receives FDA Orphan Drug Designation for AP303 in ADPKD Treatment

 Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for th...

 April 01, 2024 | News

GenFleet Therapeutics Collaborates with BeiGene for Advanced Lymphoma Trial

GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced it has entered into ...

 March 29, 2024 | News

Lunit Reveals Positive Study Results for Head and Neck Cancer Immunotherapy

Lunit, a global leader in AI-driven cancer diagnostics and therapy solutions, is thrilled to share the publication of a groundbreaking study in the prestig...

 March 27, 2024 | News

TiumBio Initiates Phase 1b Trial for New Hemophilia Treatment TU7710

TiumBio Co., Ltd., a trailblazer in the biopharmaceutical landscape, dedicated to crafting groundbreaking therapies for rare and untreatabl...

 March 27, 2024 | News

Nanoscope Therapeutics Achieves Breakthrough in Retinitis Pigmentosa Treatment with MCO-010 Gene Therapy

Nanoscope Therapeutics, a pioneering biotechnology firm, unveiled groundbreaking results from the Phase 2b RESTORE trial of MCO-010...

 March 27, 2024 | News

Alphamab Oncology Launches Groundbreaking Clinical Trial in Australia for Advanced Cancer Treatment

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed in Australia in the clinical study (JSKN033-101) of JSKN0...

 March 26, 2024 | News

India Launches Pioneering Trials for MTBVAC TB Vaccine by Biofabri and Bharat Biotech to Revolutionize Global TB Prevention

Innovative Tuberculosis Vaccine, MTBVAC, Enters Clinical Trials in India In a major leap forward in the fight against tuberculosis (TB)—a deadly inf...

 March 24, 2024 | News

Vertex Pharmaceuticals Receives FDA Clearance for Innovative ADPKD Drug Trial

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) f...

 March 22, 2024 | News

Oscotec Inc. Gains FDA Orphan Drug Designation for Promising ITP Treatment Cevidoplenib

Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immun...

 March 22, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close